title: Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.
authors.forename: Anderson
authors.initials: A
authors.lastname: Teixeira
authors.forename: Nilva
authors.initials: N
authors.lastname: Moraes
authors.forename: Michel Eid
authors.initials: ME
authors.lastname: Farah
authors.forename: Pedro Paulo
authors.initials: PP
authors.lastname: Bonomo
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000793:Angioid Streaks / Q000150:complications*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D008297:Male; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab